Changes in T-cell proliferative responses to GPIIb/IIIa and tetanus toxoid after a single injection of IDEC-131/E6040
. | Stimulation index of antigen-specific T-cell proliferation . | . | . | ||
---|---|---|---|---|---|
IDEC-131/E6040 dose . | Day 0 pretreatment . | Day 7 after treatment . | Day 42 after treatment . | ||
GPIIb/IIIa-specific T-cell response | |||||
2 mg/kg | 2.3 ± 0.8 | 2.6 ± 1.5 | 2.2 ± 1.5 | ||
5 mg/kg | 6.5 ± 4.9 | 4.6 ± 4.1 | 2.3 ± 1.2 | ||
10 mg/kg | 8.3 ± 5.9 | 4.7 ± 5.1* | 3.2 ± 1.0† | ||
Tetanus toxoid-specific T-cell response | |||||
2 mg/kg | 4.9 ± 2.0 | 5.0 ± 3.3 | 3.3 ± 1.9 | ||
5 mg/kg | 1.9 ± 1.6 | 1.9 ± 1.5 | 2.6 ± 2.6 | ||
10 mg/kg | 4.5 ± 3.2 | 4.0 ± 2.6 | 3.5 ± 1.8 |
. | Stimulation index of antigen-specific T-cell proliferation . | . | . | ||
---|---|---|---|---|---|
IDEC-131/E6040 dose . | Day 0 pretreatment . | Day 7 after treatment . | Day 42 after treatment . | ||
GPIIb/IIIa-specific T-cell response | |||||
2 mg/kg | 2.3 ± 0.8 | 2.6 ± 1.5 | 2.2 ± 1.5 | ||
5 mg/kg | 6.5 ± 4.9 | 4.6 ± 4.1 | 2.3 ± 1.2 | ||
10 mg/kg | 8.3 ± 5.9 | 4.7 ± 5.1* | 3.2 ± 1.0† | ||
Tetanus toxoid-specific T-cell response | |||||
2 mg/kg | 4.9 ± 2.0 | 5.0 ± 3.3 | 3.3 ± 1.9 | ||
5 mg/kg | 1.9 ± 1.6 | 1.9 ± 1.5 | 2.6 ± 2.6 | ||
10 mg/kg | 4.5 ± 3.2 | 4.0 ± 2.6 | 3.5 ± 1.8 |